Buscar
Mostrando ítems 1-10 de 41
Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio Eradication
(Frontiers Media Sa, 2017)
Immunodeficiency-associated vaccine-derived polioviruses (iVDPVs) have been isolated from primary immunodeficiency (PID) patients exposed to oral poliovirus vaccine (OPV). Patients may excrete poliovirus strains for months ...
Rotavirus Serum IgA Immune Response in Children Receiving Rotarix Coadministered With bOPV or IPV
(2016)
Background: Vaccine schedules including bivalent oral and inactivated
poliovirus vaccines will replace trivalent oral poliovirus vaccines in 2016.
Methods: We evaluated rotavirus immunoglobulin A seroresponses when
the ...
Avaliação da imunização precoce contra poliomielite em recém-nascidos com uso de vacina oral trivalente de vírus vivos atenuados
(Universidade Federal de São Paulo (UNIFESP), 1989)
Patients with primary immunodeficiencies are a reservoir of poliovirus and a risk to polio eradication
(Frontiers Research FoundationInmunodeficiencias PrimariasSuiza, 2019)
Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial
(Lancet Publishing Group, 2016)
© 2016 Elsevier Ltd Background Replacement of the trivalent oral poliovirus vaccine (tOPV) with bivalent types 1 and 3 oral poliovirus vaccine (bOPV) and global introduction of inactivated poliovirus vaccine (IPV) are major ...
Vaccine schedule compliance among very low birth weight infants in Lima, Peru
(Elsevier, 2015)
OBJECTIVE: There is little information about vaccine schedule compliance in very-low-birth-weight infants in developing countries. The aim of the study was to describe the compliance with the vaccine schedule among this ...
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
(Elsevier Ltd., 2015)
Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one dose of inactivated poliovirus vaccine (IPV) in routine ...
Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
(Elsevier Ltd., 2015)
Bivalent oral poliovirus vaccine (bOPV; types 1 and 3) is expected to replace trivalent OPV (tOPV) globally by April, 2016, preceded by the introduction of at least one dose of inactivated poliovirus vaccine (IPV) in routine ...